Drug intelligence / Profile preview

bone marrow-derived mesenchymal stem cells (autologous)

Development stage
Unknown
Lead developer
StemiGen
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intraarticular
01

Overview

Bone marrow-derived mesenchymal stem cells (autologous) is a cell therapy being developed by StemiGen for the treatment of knee osteoarthritis. This autologous therapy involves harvesting mesenchymal stem cells (MSCs) from the patient's own bone marrow, which are then processed and administered via intra-articular injection into the affected knee joint. The therapeutic mechanism is based on the regenerative and immunomodulatory properties of MSCs, which secrete various bioactive molecules that promote tissue repair, reduce inflammation, and potentially slow the progression of joint degeneration. The product is currently in Phase 1/2 clinical trials to evaluate its safety and efficacy in improving joint function and reducing pain in patients with osteoarthritis.

Other names
Autologous bone marrow-derived MSCsStemiGen autologous MSC therapy

Beyond the preview

Go deeper on bone marrow-derived mesenchymal stem cells (autologous).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bone marrow-derived mesenchymal stem cells (autologous).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call